MediPoint: Digit Replacement - Middle East and Africa Analysis and Market Forecasts
|出版日||ページ情報||英文 27 Pages
|指関節置換：中東・アフリカ市場の分析と予測 MediPoint: Digit Replacement - Middle East and Africa Analysis and Market Forecasts|
|出版日: 2017年03月02日||ページ情報: 英文 27 Pages||
中東およびアフリカの指関節置換市場は、2016年には40万米ドル、2023年には50万米ドルと、3.2%のCAGR (複合年間成長率) で成長する、と見込まれています。
当レポートでは、中東・アフリカ諸国における指関節置換市場について分析し、全体的な処置件数・売上高・平均価格の動向 (過去3年間・今後7年間分) や、国別の詳細動向、主な市場促進・抑制要因、主要企業のプロファイル・競争力・最新情勢などを調査しております。
Painful motion around the metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints is often precipitated by conditions such as arthritis, neuromuscular diseases, trauma, connective tissue disorder, and biomechanical instability, which can interfere with daily activities. This is generally addressed using conservative methods including physical therapy and nonsteroidal anti-inflammatory drugs (NSAIDs). Digit replacement is a surgical procedure mainly performed to relieve pain and restore function by replacing damaged joint surfaces with artificial implants. The major risk factors that contribute to digit replacement are osteoarthritis and rheumatoid arthritis resulting from old age.
Digit replacement is an intervention indicated for dysfunction of the finger joint due to trauma or arthritis. It is a substitute to arthrodesis when joint pain begins to interfere with daily activities and other medical management routes fail to provide relief. The procedure is complicated and there is a steep learning curve to competency as low procedure numbers prevent surgeons from getting enough hands-on experience. The goal of digit arthroplasty is to relieve pain, fix deformities and maintain the function and appearance of the fingers. Compared to other arthroplasties, the market share of digit replacement is paltry and therefore its addition to a company's portfolio is normally a strategic business decision.
The Middle East and Africa digit replacement market was estimated at $0.4M in 2016 across the ME&A markets (Egypt, Israel, Saudi Arabia, South Africa, and United Arab Emirates [UAE]) covered in this report. By the end of the forecast period in 2023, it is estimated that the market will grow to approximately $0.5M at a Compound Annual Growth Rate (CAGR) of 3.2%.
Key drivers of the digit replacement market in the forecast period are -
The Middle East and Africa digit replacement market is projected to grow at a CAGR of 3.2% during the forecast period. South Africa represented the largest portion of the market in 2016, holding more than 40% of the regional revenue, and is expected to maintain this dominance through the forecast period. South Africa is also expected to be the fastest-growing market in the Middle East and African market through 2023, at a CAGR of 6%, while every other country in the region will experience negligible growth.
The market for digit replacement is divided into two product categories: silicone and pyrolytic-based implants. The most popular finger implant is the silicone-based Swanson prosthesis, the gold standard upon which several silicone finger joint prostheses designs are based. Other players in this market include Integra LifeSciences, Stryker, Wright Medical, Zimmer Biomet, and Depuy Orthopedics.
The report "MediPoint: Digit Replacement - Middle East and Africa Analysis and Market Forecasts", focuses on the market outlook for digit replacement devices in the Middle East and Africa (Egypt, Israel, Saudi Arabia, South Africa, and United Arab Emirates). The analysis identifies the key unmet needs in the digit replacement market, discusses the major drivers and barriers of adoption, and provides an in-depth understanding of physicians' perceptions and the future outlook for this market by segment and geography.
Companies mentioned in this report: Integra LifeSciences, Stryker, Wright Medical, Zimmer Biomet, Depuy Orthopaedics.